Site records / Karnataka / FEI 3007078919

Apotex Research Private LimitedBangalore, Karnataka

FDA-registered drug establishment in Bangalore, Karnataka: analysis. Registration valid to 31 Dec 2026. Record as observed 27 Sep 2026.

Inspections posted
3
Last inspection
May 2026 · NAI
Warning letters to this FEI
0
Import alerts at this address
0
US border refusals, 2 years
0
The site dossier

This site, graded.
Every fact sourced.

  • A grade from A to E on a registered ten-factor rubric, with the fact behind every factor
  • Every posted FDA citation, sorted into failure categories and set against Indian drug inspections
  • Warning-letter violations, numbered and labelled
  • Import-alert history rebuilt from the archive, each listing checked against this address
  • Border refusals by product, and the company's other sites, each graded
  • A hash of every source read, so the PDF can be checked against the record

On 2022–26 inspections the rubric never saw, grade E sites were classified OAI 26.5% of the time and grade A sites 4.0%.

PDF and data by email, usually within minutes, as of the day you buy. Card payment through Razorpay.

By buying you agree to the Terms and the refund policy: sales are final once delivered, except non-delivery.

Consultant plan · US$799 a month · five dossiers a month and watchlist alerts. Ask about the plan

Inspections

3 FDA inspections of this FEI, by end date; 3 with a posted classification.

  1. 8 May 2026NAI · No Action IndicatedBioresearch Monitoring · no citations posted
  2. 13 Dec 2024VAI · Voluntary Action IndicatedBioresearch Monitoring · no citations posted
  3. 7 Dec 2018NAI · No Action IndicatedBioresearch Monitoring · no citations posted

Warning letters and compliance actions

  1. 31 Oct 2025Warning letter to Apotex Inc. SourceCGMP/Finished Pharmaceuticals/Adulterated · issued to the firm name; FDA does not tie it to this FEI
  2. 30 Jan 2015Warning letter to Apotex Research Private Limited SourceCGMP/Finished Pharmaceuticals/Adulterated · issued to the firm name; FDA does not tie it to this FEI
  3. 21 Feb 2013Warning letter to Apotex Inc SourceCGMP/Finished Pharmaceuticals/Adulterated/Misbranded · issued to the firm name; FDA does not tie it to this FEI
  4. 29 Mar 2010Warning letter to Apotex Inc. SourceCGMP for Finished Pharmaceuticals/Adulterated · issued to the firm name; FDA does not tie it to this FEI

Import alerts in force

No listing in force under this firm's name.

Other registered sites of Apotex Inc.

Registration

FEI
3007078919
DUNS
650081412
Registered as
Apotex Research Private Limited
Registrant
Apotex Inc.
Address
Bioequivalence Center, Site No. 2, Bommasandra Industrial Area, Phase IV, Jigani Link Road, Bangalore, Karnataka 560099, India (IND)
Operations
ANALYSIS
Registration expires
31 Dec 2026

Sources: FDA drug establishment registrations, FDA Data Dashboard inspections and compliance actions, import-alert pages, warning letters, import refusals and the FDA reading room, as held in Counterfoil's point-in-time corpus. No matched action does not establish compliance, and FDA registration is not FDA approval. Sources and coverage.

COUNTERFOIL / CONTACT

Contact us.

How can we help?

Stored privately by Counterfoil. Your email is used only to respond to your enquiry.